The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases
Identifieur interne : 001E29 ( Main/Exploration ); précédent : 001E28; suivant : 001E30The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases
Auteurs : S. Mahajan [États-Unis] ; W. M. Atkins [États-Unis]Source :
- Cellular and Molecular Life Sciences CMLS [ 1420-682X ] ; 2005-06-01.
English descriptors
- KwdEn :
Abstract
Abstract.: The cytosolic glutathione S-transferases are a family of structurally homologous enzymes with multiple functions, including xenobiotic detoxification, clearance of oxidative stress products, and modulation of cell proliferation and apoptosis signaling pathways. This wideranging functional repertoire leads to several possible therapeutic uses for isoform-specific GST inhibitors. These inhibitors may be used, in principle, to modulate tumor cell drug resistance, as sensitizers to therapeutically directed oxidative stress, to enhance cell proliferation and to augment anti-malarial drugs. With increasing knowledge of GST structural and function, rational design strategies and mechanism-based inhibitors have been exploited successfully. However, design of isoform specificity remains a significant challenge in GST inhibitor development. Strategies for further inhibitor design and their possible limitations, along with potential therapeutic uses, are summarized.
Url:
DOI: 10.1007/s00018-005-4524-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000F89
- to stream Istex, to step Curation: 000F89
- to stream Istex, to step Checkpoint: 000C79
- to stream Main, to step Merge: 001E43
- to stream Main, to step Curation: 001E29
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases</title><author><name sortKey="Mahajan, S" sort="Mahajan, S" uniqKey="Mahajan S" first="S." last="Mahajan">S. Mahajan</name></author><author><name sortKey="Atkins, W M" sort="Atkins, W M" uniqKey="Atkins W" first="W. M." last="Atkins">W. M. Atkins</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:31DAF0D61D498C910B8EA630A2160B1CD9A14E78</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1007/s00018-005-4524-6</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-4DGW9G2B-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000F89</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F89</idno><idno type="wicri:Area/Istex/Curation">000F89</idno><idno type="wicri:Area/Istex/Checkpoint">000C79</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C79</idno><idno type="wicri:doubleKey">1420-682X:2005:Mahajan S:the:chemistry:and</idno><idno type="wicri:Area/Main/Merge">001E43</idno><idno type="wicri:Area/Main/Curation">001E29</idno><idno type="wicri:Area/Main/Exploration">001E29</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases</title><author><name sortKey="Mahajan, S" sort="Mahajan, S" uniqKey="Mahajan S" first="S." last="Mahajan">S. Mahajan</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicinal Chemistry, University of Washington, Box 357610, 98195-7610, Seattle</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Atkins, W M" sort="Atkins, W M" uniqKey="Atkins W" first="W. M." last="Atkins">W. M. Atkins</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicinal Chemistry, University of Washington, Box 357610, 98195-7610, Seattle</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Cellular and Molecular Life Sciences CMLS</title><title level="j" type="abbrev">CMLS, Cell. Mol. Life Sci.</title><idno type="ISSN">1420-682X</idno><idno type="eISSN">1420-9071</idno><imprint><publisher>Birkhäuser-Verlag; www.birkhauser.ch</publisher><pubPlace>Basel</pubPlace><date type="published" when="2005-06-01">2005-06-01</date><biblScope unit="volume">62</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1221">1221</biblScope><biblScope unit="page" to="1233">1233</biblScope></imprint><idno type="ISSN">1420-682X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1420-682X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Drug design</term><term>anti-malarial drugs</term><term>cancer chemotherapy</term><term>glutathione analogs</term><term>oxidative stress</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract.: The cytosolic glutathione S-transferases are a family of structurally homologous enzymes with multiple functions, including xenobiotic detoxification, clearance of oxidative stress products, and modulation of cell proliferation and apoptosis signaling pathways. This wideranging functional repertoire leads to several possible therapeutic uses for isoform-specific GST inhibitors. These inhibitors may be used, in principle, to modulate tumor cell drug resistance, as sensitizers to therapeutically directed oxidative stress, to enhance cell proliferation and to augment anti-malarial drugs. With increasing knowledge of GST structural and function, rational design strategies and mechanism-based inhibitors have been exploited successfully. However, design of isoform specificity remains a significant challenge in GST inhibitor development. Strategies for further inhibitor design and their possible limitations, along with potential therapeutic uses, are summarized.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Washington (État)</li></region><settlement><li>Seattle</li></settlement><orgName><li>Université de Washington</li></orgName></list><tree><country name="États-Unis"><region name="Washington (État)"><name sortKey="Mahajan, S" sort="Mahajan, S" uniqKey="Mahajan S" first="S." last="Mahajan">S. Mahajan</name></region><name sortKey="Atkins, W M" sort="Atkins, W M" uniqKey="Atkins W" first="W. M." last="Atkins">W. M. Atkins</name><name sortKey="Atkins, W M" sort="Atkins, W M" uniqKey="Atkins W" first="W. M." last="Atkins">W. M. Atkins</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:31DAF0D61D498C910B8EA630A2160B1CD9A14E78
|texte= The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases
}}
| This area was generated with Dilib version V0.6.33. |  |